Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice.
Agid O, Crespo-Facorro B, de Bartolomeis A, Fagiolini A, Howes OD, Seppälä N, Correll CU. Agid O, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2024 Apr 23;84:35-47. doi: 10.1016/j.euroneuro.2024.04.012. Online ahead of print. Eur Neuropsychopharmacol. 2024. PMID: 38657339 Review.
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery.
Arango C, Fagiolini A, Gorwood P, Kane JM, Diaz-Mendoza S, Sahota N, Correll CU. Arango C, et al. Among authors: correll cu. Res Sq [Preprint]. 2023 Mar 8:rs.3.rs-2594278. doi: 10.21203/rs.3.rs-2594278/v1. Res Sq. 2023. PMID: 36945577 Free PMC article. Updated. Preprint.
Effect modification of an effective transdiagnostic cognitive behavioral psychotherapy in youths with common mental health problems: Secondary analyses of the randomized mind-my-mind trial.
Rimvall MK, Vassard D, Nielsen SM, Wolf RT, Plessen KJ, Bilenberg N, Thomsen PH, Thastum M, Neumer SP, Puggaard LB, Pedersen MMA, Pagsberg AK, Silverman WK, Correll CU, Christensen R, Jeppesen P. Rimvall MK, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2023 Sep;74:64-75. doi: 10.1016/j.euroneuro.2023.05.004. Epub 2023 Jun 4. Eur Neuropsychopharmacol. 2023. PMID: 37279641 Free article. Clinical Trial.
Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study.
Martini J, Bröckel KL, Leopold K, Berndt C, Sauer C, Maicher B, Juckel G, Krüger-Özgürdal S, Fallgatter AJ, Lambert M, Bechdolf A, Reif A, Matura S, Biere S, Kittel-Schneider S, Stamm T, Bermpohl F, Kircher T, Falkenberg I, Jansen A, Dannlowski U, Correll CU, Fusar-Poli P, Hempel LM, Mikolas P, Ritter P, Bauer M, Pfennig A. Martini J, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2024 Jan;78:43-53. doi: 10.1016/j.euroneuro.2023.10.001. Epub 2023 Oct 30. Eur Neuropsychopharmacol. 2024. PMID: 37913697 Free article.
An international research agenda for clozapine-resistant schizophrenia.
Luykx JJ, Gonzalez-Diaz JM, Guu TW, van der Horst MZ, van Dellen E, Boks MP, Guloksuz S, DeLisi LE, Sommer IE, Cummins R, Shiers D, Lee J, Every-Palmer S, Mhalla A, Chadly Z, Chan SKW, Cotes RO, Takahashi S, Benros ME, Wagner E, Correll CU, Hasan A, Siskind D, Endres D, MacCabe J, Tiihonen J. Luykx JJ, et al. Among authors: correll cu. Lancet Psychiatry. 2023 Aug;10(8):644-652. doi: 10.1016/S2215-0366(23)00109-8. Epub 2023 Jun 14. Lancet Psychiatry. 2023. PMID: 37329895 Review.
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations.
Turkoz I, Daskiran M, Siddiqui U, Knight RK, Johnston KL, Correll CU. Turkoz I, et al. Among authors: correll cu. Int J Neuropsychopharmacol. 2024 Feb 1;27(2):pyad067. doi: 10.1093/ijnp/pyad067. Int J Neuropsychopharmacol. 2024. PMID: 38300235 Free PMC article. Clinical Trial.
873 results